You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bendamustine Hydrochloride

Showing 51 - 75 of 2,057
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Waldenstrom Macroglobulinemia Trial in Tianjin (Zanubrutinib, Bendamustine and Rituximab)

Recruiting
  • Waldenstrom Macroglobulinemia
  • Zanubrutinib, Bendamustine and Rituximab
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jun 13, 2023

Mantle Cell Lymphoma, Non-hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Madison (Bendamustine, Obinutuzumab)

Recruiting
  • Mantle Cell Lymphoma
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Sep 13, 2022

Lymphoma, Mantle Cell Trial in Worldwide (Acalabrutinib, Bendamustine, Rituximab)

Recruiting
  • Lymphoma, Mantle Cell
  • Downey, California
  • +231 more
Jan 16, 2023

Lymphoma Trial in United States (rituximab, bendamustine HCl, cyclophosphamide)

Completed
Has Results
  • Lymphoma
  • rituximab
  • +8 more
  • Duarte, California
  • +203 more
Oct 14, 2021

Mantle Cell Lymphoma, Lymphoma Trial in United States (BR-I (bendamustine, rituximab, ibrutinib), VEN (Venetoclax))

Active, not recruiting
  • Mantle Cell Lymphoma
  • Lymphoma
  • BR-I (bendamustine, rituximab, ibrutinib)
  • VEN (Venetoclax)
  • Basking Ridge, New Jersey
  • +6 more
Feb 3, 2022

Leukemia, Lymphocytic, Chronic, B-Cell Trial in Austria (Bendamustine, Alemtuzumab)

Completed
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Innsbruck, Tirol, Austria
  • +6 more
Feb 15, 2022

Hodgkin Disease Trial in Worldwide (Nivolumab, brentuximab vedotin, bendamustine)

Active, not recruiting
  • Hodgkin Disease
  • Nivolumab
  • +2 more
  • Birmingham, Alabama
  • +77 more
Jul 21, 2022

Non-Hodgkin's Lymphoma Trial in Philadelphia (drug, procedure, genetic)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Sep 14, 2022

Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib (ACP-196), Rituximab, Idelalisib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Acalabrutinib (ACP-196)
  • +3 more
  • Chandler, Arizona
  • +156 more
Jun 2, 2022

DLBCL, DLBCL Trial in Worldwide (Zilovertamab vedotin, Rituximab, Gemcitabine)

Recruiting
  • DLBCL
  • Diffuse Large B-Cell Lymphoma
  • Zilovertamab vedotin
  • +4 more
  • Whittier, California
  • +21 more
Nov 30, 2022

DLBCL, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Ublituximab, Umbralisib, Bendamustine)

Terminated
  • Diffuse Large B-Cell Lymphoma
  • +4 more
  • Ublituximab
  • +2 more
  • Birmingham, Alabama
  • +167 more
Jul 20, 2022

Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Obinutuzumab, Venetoclax, Fludarabine)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Aurora, Colorado
  • +55 more
Jan 30, 2023

Lymphoma Trial in Worldwide (Parsaclisib, Hexal, Gazyvaro)

Completed
  • Lymphoma
  • Gilbert, Arizona
  • +20 more
Dec 1, 2021

Follicular Lymphoma (FL), Non Hodgkin Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Zandelisib, Rituximab, Bendamustine)

Recruiting
  • Follicular Lymphoma (FL)
  • +2 more
  • Tucson, Arizona
  • +134 more
Jul 27, 2022

Hodgkin's Lymphoma Trial in Poland (drug, diagnostic test, procedure)

Recruiting
  • Hodgkin's Lymphoma
  • Bydgoszcz, Poland
  • +12 more
Dec 23, 2021

Marginal Zone B-cell Lymphoma Trial in Korea, Republic of (bendamustine plus rituximab)

Completed
  • Marginal Zone B-cell Lymphoma
  • bendamustine plus rituximab
  • Jeonju, Jeollabuk-do, Korea, Republic of
  • +10 more
Sep 23, 2021

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in United States (Obinutuzumab, Bendamustine,

Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Tempe, Arizona
  • +14 more
Jan 12, 2022

Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in United States (Bendamustine

Suspended
  • Grade 1 Follicular Lymphoma
  • +4 more
  • Bendamustine Hydrochloride
  • +13 more
  • Anchorage, Alaska
  • +422 more
Feb 2, 2023

Relapsed/Refractory B-Cell Lymphoma Trial (FT522, Rituximab, Cyclophosphamide)

Not yet recruiting
  • Relapsed/Refractory B-Cell Lymphoma
  • (no location specified)
Jul 10, 2023

Mantle Cell Lymphoma Trial (parsaclisib, rituximab, bendamustine)

Withdrawn
  • Mantle Cell Lymphoma
  • (no location specified)
Apr 22, 2022

Lymphoma Trial in Cairo (BEAM Protocol, CEM protocol)

Recruiting
  • Lymphoma
  • BEAM Protocol
  • CEM protocol
  • Cairo, Egypt
    International Medical Center (IMC) Hospital, Cairo, Egypt.
Apr 1, 2023

Hematopoietic and Lymphoid System Tumor Trial in Houston (procedure, drug, biological, radiation)

Recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2022

Obinutuzumab-based Therapy for Previously Untreated FL

Recruiting
  • Follicular Lymphoma
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Jun 3, 2023

Multiple Myeloma Trial in Berne (Melphalan, Bendamustine)

Completed
  • Multiple Myeloma
  • Berne, Switzerland
    Department for Medical Oncology University Hospital/Inselspital
Jul 29, 2021

B-cell Non Hodgkin Lymphoma, Richter's Transformation Trial in United States (Cosibelimab, Cosibelimab + Ublituximab +

Terminated
  • B-cell Non Hodgkin Lymphoma
  • Richter's Transformation
  • Cosibelimab
  • Cosibelimab + Ublituximab + Bendamustine combination
  • Huntsville, Alabama
  • +8 more
Aug 19, 2022